1mg
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$6.0m | Series A | ||
N/A | Seed | ||
$15.0m | Series C | ||
$10.1m | Series C | ||
N/A | $10.3m | Series D | |
* | €8.9m | Late VC | |
N/A | $17.8m | Debt | |
$13.3m | Debt | ||
* | $40.0m Valuation: $1.3b | Late VC | |
Total Funding | AUD141m |
Recent News about 1mg
Edit1mg is a comprehensive online healthcare platform that serves a wide range of clients including individuals seeking affordable medicines, lab tests, and medical consultations. Operating in the Indian healthcare market, 1mg's business model revolves around providing a one-stop solution for various health-related needs. The platform offers a vast selection of medicines, both prescription and over-the-counter, sourced from verified and licensed pharmacies. Additionally, 1mg provides access to accredited labs for diagnostic tests, often at discounted rates, and offers free online doctor consultations to its users. The company generates revenue through the sale of medicines, health products, lab tests, and premium subscription services. By leveraging technology, 1mg ensures secure transactions and data protection, adhering to industry standards like SSL encryption and PCI DSS compliance. The platform also features a rich repository of medical information curated by experts, making it a trusted source for health-related content.
Keywords: online healthcare, affordable medicines, lab tests, medical consultations, verified pharmacies, accredited labs, secure transactions, expert content, Indian market, health products.